Parallax Volatility Advisers
VNDA icon

Parallax Volatility Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

Parallax Volatility Advisers’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,000
Closed -$235K – 3246
2021
Q4 		$235K Hold
15,000
– – ﹤0.01% 1617
2021
Q3 		$257K Buy
+15,000
New +$263K ﹤0.01% 1661

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Parallax Volatility Advisers's VNDA Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Vanda Pharmaceuticals (VNDA) in Q1 2019, closing a stake of 4,203 shares — an estimated $110K sold.

Parallax Volatility Advisers first reported a position in VNDA in Q3 2017 and held it in 3 quarters. The position peaked at $1.11M in Q3 2017. 179 funds tracked by Wall St. Rank hold VNDA as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining Vanda Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,203 Vanda Pharmaceuticals shares in Q1 2019, an estimated $110K.
  • Parallax Volatility Advisers first reported a position in Vanda Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Vanda Pharmaceuticals position peaked at $1.11M in Q3 2017.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.